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Background: The ongoing pandemic is having a collateral health effect on delivery of surgical care to
millions of patients. Very little is known about pandemic management and effects on other services,
including delivery of surgery.
Methods: This was a scoping review of all available literature pertaining to COVID-19 and surgery, using
electronic databases, society websites, webinars and preprint repositories.
Results: Several perioperative guidelines have been issued within a short time. Many suggestions are
contradictory and based on anecdotal data at best. As regions with the highest volume of operations
per capita are being hit, an unprecedented number of operations are being cancelled or deferred.
No major stakeholder seems to have considered how a pandemic deprives patients with a surgical
condition of resources, with patients disproportionally affected owing to the nature of treatment (use of
anaesthesia, operating rooms, protective equipment, physical invasion and need for perioperative care).
No recommendations exist regarding how to reopen surgical delivery. The postpandemic evaluation and
future planning should involve surgical services as an essential part to maintain appropriate surgical care
for the population during an outbreak. Surgical delivery, owing to its cross-cutting nature and synergistic
effects on health systems at large, needs to be built into the WHO agenda for national health planning.
Conclusion: Patients are being deprived of surgical access, with uncertain loss of function and risk of
adverse prognosis as a collateral effect of the pandemic. Surgical services need a contingency plan for
maintaining surgical care in an ongoing or postpandemic phase.
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Introduction
The pandemic of COVID-19 caused by the coronavirus
SARS-CoV-21 is disrupting global health, social welfare
and the economy in a proportion unparalleled in modern
history. In addition to the effects of the disease itself on
public health, a collateral effect from near-universal disrup-
tion and cancellation of surgical services has emerged.
Although the seasonal disruption of surgical care and
the occasional cancellation of surgery is not new to
most healthcare systems2–4, the current pandemic has
unprecedented implications for surgical services and
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patients with surgical conditions5. Surgical capacity may
experience extreme challenges in war zones6,7, or in the
case of mass casualty events from terror or during civilian
accidents or natural disasters, with numbers exceeding the
surgical capacity (such as operating theatres, number of
surgeons and anaesthesia staff). In the current pandemic,
rather than mobilizing surgical resources for surgical
conditions in need, the current demand for ventilators,
hospital space and personnel is depriving surgical capacity
to a point where essential surgical delivery is strained in
multiple regions, irrespective of their economic classifica-
tion. This is having an immediate and long-term effect on
millions of patients with surgical conditions worldwide.
Globally, there have been deficits in surgical service prepa-
ration, delivery and recovery from the pandemic; lessons
can be learned from countries in each phase of response.
Methods
An international collaborative of co-investigators represen-
tative of several surgical disciplines, geographical regions
and with experience ranging from administrative leader-
ship roles to frontline practice were involved. A detailed
description of the search strategy, inclusion and exclu-
sion criteria, and results are provided in Tables S1 and S2,
Fig. S1 and Appendix S1 (supporting information). A scop-
ing review approach was used8–10.
Impact of pandemic on surgical services
Based on the available reports and evolving real-time
experience, the pandemic effects on surgery are profound,
potentially long-lasting and extensive. Studies5,11–26
identified in relation to surgery and perioperative care
comprised opinions, anecdotal reports and recommen-
dations. Several national surgical societies had launched
COVID-19-specific guidelines with dynamic updates, in
addition to over 20 subdiscipline-specific surgical and
perioperative guidelines (Table 1; Table S3, supporting
information). Of particular note, information related to
surgical services in a pandemic was scarce on the WHO
website27.
Several generic themes are similar across regions, and
may be used to mitigate the effects of the pandemic on
surgical services, both in the short term and in the longer
term, and to learn from for preparedness for future possible
events.
From a public health perspective, the modelled response
and effects are largely dependent on the slope of increase
of diseased and critically ill patients, and how the peak of
the pandemic curve evolves in order to cope with emerging
needs (Fig. 1)28. The ability of surgical services to maintain
a role depends on the peak of the pandemic, the spread
of the disease, the duration of societal regulations, and
the duration and temporal epidemic repeats by which the
disease burden will approach the threshold of maximum
capacity of the critical care resources (Fig. 1). Even in a
situation where the threshold may not be exceeded, one
may expect capacity to be close to, or temporarily breached,
before the pandemic fades.
Addressing pandemic preparedness phase
In regions where hospital networks already exist, attempts
at developing ‘COVID-19’ and ‘non-COVID-19’ hospitals
may be a reasonable way to preserve surgical services and
normal function, while containing the diseased population
away from the non-diseased. Suggestions of how tomanage
this within and between hospitals have been proposed
elsewhere29–31.
Reorganization of surgical services to hospitals
and designated pathways
The success of pandemic preparedness and resilience of the
system is largely dependent on the scale of the outbreak,
the time frame and the pressure on health systems5,32. A
hub-and-spoke model was used in the Lombardy region of
Italy (Appendix S2, supporting information). However, this
model may be feasible only until community transmission
reaches a critical threshold.
At the institutional level, creating within-hospital path-
ways for ‘clean’ and ‘contaminated’ patient flow is essential
to maintain open routes for regular diagnosis and treat-
ment. Where resources allow, one should declare ded-
icated COVID-19 radiology units (CT scanners, etc.),
wards, operating theatres and endoscopy suites. Such orga-
nization may imply having COVID-19-dedicated teams of
healthcare professionals. Using separate pathways at the
institutional level can also support rapid outbreaks where
system-level ‘COVID-19’ and ‘non-COVID-19’ hospitals
are not feasible, or when the pandemic reaches a state when
hospital designation is no longer sustainable. However, a
breakdown of barriers by hospital designation, by separated
wards or clinical pathway designation should be prevented
or mitigated to avoid uncontrolled spread of disease.
Designation of hospitals, care areas and healthcare pro-
fessionals for COVID-19 care should be implemented early
on to delay and prevent progression of the outbreak via
healthcare institutions and professionals. Once the pan-
demic reaches a critical threshold through community
transmission, these models may not be sustainable, and
broader reorganization of care becomes necessary.
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Table 1 Organizations providing perioperative guidelines for patients with COVID-19
Health systems guidelines Anaesthesia guidelines Surgical guidelines Subspecialty-specific guidelines
Centers for Disease Control
and Prevention
European Centre for
Disease Prevention and
Control
Government of Australia
United States Department
of Defense
American Society of
Anesthesiologists
Canadian
Anesthesiologists’
Society
Faculty of Intensive Care
Medicine, Intensive Care
Society, Association of
Anaesthetists, and Royal
College of Anaesthetists
Italian College of
Anaesthesia, Analgesia,
Resuscitation, and
Intensive Care (SIAARTI)
South African Society of
Anaesthesiologists
World Federation of
Societies of
Anaesthesiologists
American College of
Surgeons
French Surgical
Association
German Society of Surgery
Italian Society of Surgery
(SIC) and Italian
Association of Hospital
Surgeons (ACOI)
Philippine College of
Surgeons
Royal Australasian College
of Surgeons
Royal College of Surgeons
of England
Royal College of Surgeons
of Ireland
Spanish Society of
Surgery
Swedish Surgical Society
The Association of
Surgeons of South
Africa
The Pan African
Association of Surgeons
American Academy of
Ophthalmology
American Academy of
Orthopedic Surgeons
American Academy of
Otolaryngology
American Association of
Oral and Maxillofacial
Surgery
American Association for
the Surgery of Trauma
American College of
Obstetrics and
Gynecology, Society for
Maternal Fetal Medicine
American Dental
Association
American Pediatric Surgical
Association
American Society of Breast
Surgeons
American Society for
Gastrointestinal
Endoscopy
American Society of
Transplant Surgeons
American Urological
Association
Americas
Hepato-Pancreato-Biliary
Association
Australian Society of
Otolaryngology Head and
Neck Surgery
British Association of
Paediatric Surgeons
European Society of
Surgical Oncology
German Society of General
and Visceral Surgery
Philippine Association of
HPB Surgeons
Royal College of
Obstetricians and
Gynaecologists
Sociedade Brasileira de
Pneumologia e Tisiologia,
Asociación
Latinoamericana de Tórax
Sociedad Española de
Neumología y Cirugía
Torácica
Society of American
Gastrointestinal and
Endoscopic Surgeons &
European Association for
Endoscopic Surgery
Society of Surgical
Oncology
Society of Thoracic
Surgeons
Society for Vascular Surgery
World Society of Emergency
Surgery
Societies with available COVID-19-specific information or recommendations on 10 April 2020. HPB, hepatopancreatobiliary.
Reorganization of surgical services to critical care
capacity
In the extreme case when waves of patients are admitted
to hospital, the surge in critically ill patients may deprive
surgical services of resources to the point of exclusion.
Several regions have experienced this phenomenon and
many are planning for this scenario, with cancellation of
all non-essential surgery for an initial period33. Operat-
ing theatres and anaesthesia machines may be converted to
temporary respiratory support units. Postoperative recov-
ery rooms and intermediate-care units may be used as care
units outside regular intensive care to manage sick patients
with COVID-19. In this case, there is a real threat of dis-
ruption to all surgical services and difficulty maintaining
even critical surgical care.
In order to prepare, all non-essential elective surgery has
been recommended to be cancelled in many healthcare
systems and by surgical societies, but with variable sug-
gestions and advice across regions and disciplines (Table 1;
Table S3, supporting information). Information and advice
are changing as pressure, and needs rise and resources are
stretched. New knowledge is emerging rapidly, leading to
suggestions sometimes based on anecdotal reports at best.
In general, deferral of surgery is especially recommended
for non-urgent operations with a potential requirement
for postoperative ICU care.
Reorganization of surgical workforce
In countries where intensive care medicine is part of, or
integrated into, surgical care, there is an opportunity to
relocate surgical providers to COVID-19 management to
enhance the intensive care capacity of personnel familiar
with, or experienced in, use of ventilators. Intensive care
training is highly variable in surgical training across train-
ing systems, and actual practice and experience vary from
country to country. In the USA and Canada, surgeons
trained in critical care may be a resource for management
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Fig. 1 Pandemic burden and impact on surgical services
Situation with
ongoing pandemic
Threshold
capacity of
healthcare
system
Resume elective surgery
Day-case surgery
Outpatient clinics
Life-saving surgery only or limited
Triage of surgical patients according to
chance of survival and perceived benefit
Emergency surgery and trauma
Maintenance of selective cancer surgery
Rebuild elective capacity by priorities
Emergency surgery and trauma
Some cancer surgery? Transplants?
Delays/cancellations
High number of deaths from pandemic
High risk of non-pandemic deaths from
lack of surgical services or ICU beds
Short-term effects
 Inability to maintain emergency services
Risk of pandemic deaths shifts with time
Lower risk of non-pandemic deaths from
lack of surgical services or ICU beds
Long-term effects
 Related to cancellation or delays in access
No strategy
MitigationSuppression
High number of deaths from pandemic
Some risk of non-pandemic deaths from
lack of surgical services or ICU beds
Short- and long-term effects
 Delayed surgery      prognosis??
The threshold for a given healthcare system may be broken by a surge in infected patients. Capacity to maintain even life-saving surgery may not be
sustained (during major or minor peaks of outbreak), leading to a potential additional loss of lives unrelated to the pandemic disease itself, but as collateral
damage.Mitigation or suppression strategies may be long-lasting (tail effect) and have effects on elective and semiurgent capacity, with the risk of worsening
disease or function, or have a detrimental impact on prognosis. Models to show implications of the pandemic on various capacity scenarios are needed, as
the toll on patients and public health is potentially enormous.
of patients in need of respiratory support on a venti-
lator. In other regions, such as the Nordic countries,
all intensive care is within the domain of anaesthetists
trained in critical care. Thus, surgeons do not represent
an immediate resource for allocation to such services.
In addition, as anaesthetists will be involved in the crit-
ical care rota, their availability for surgical anaesthesia
and perioperative care will be affected. Other forms of
redirection of services are possible and needed in this
setting.
Some surgeon subspecialists who do not usually cover
emergency surgery (such as hepatobiliary surgeons and
surgical oncologists) may be called on to cover emergency
general surgery and trauma. As personnel may become
diseased or quarantined, it may be necessary to rotate staff
according to need and competence, and also to allow staff
to have breaks from periods of extreme work pressure and
intense workload.
Viral risks and effects on available workforce
With large numbers of staff being quarantined (owing to
travel, contact or cluster exposure; for example, at risk,
but not tested) or in imposed self-quarantine (sore throat,
cough or cold; not tested) or who have actually contracted
the disease (SARS-CoV-2-positive), there is also a need
to relocate personnel across surgical services to cover staff
shortages.
Appropriate personal protective equipment (PPE) is an
absolute necessity, but has proven to be a global issue,
with variable and unpredictable supply chains and delivery
networks across the globe15. For the surgical workforce
working on wards with non-infected patients, a high suspi-
cion should be maintained and social distancing principles
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applied by patients and staff (such as working in smaller
groups; splitting teams with alternating half-and-half
working at home and on site; reducing participants in
meetings; virtual participation at multidisciplinary team
meetings through telecommunication)24,34,35.
Ambulatory surgery should stop, even if low risk, as
this uses equipment and protective gear as well as hav-
ing the risk of bilateral disease spread (patient to provider
and vice versa). Reports of adverse effects and fatal out-
comes from contracting COVID-19 after ambulatory and
elective surgery are of concern14,15,25,36. Outpatient clin-
ics should be reduced to a minimum, and maintained
through alternative sources, such as video consultations.
These have long been used in remote areas to avoid long
travel distances34,37–39, but can be implemented rapidly
even in large metropolitan regions to maintain social dis-
tancing during a pandemic35.
There are currently no data to assess the impact on the
surgical (and related healthcare personnel) workforce. In
Italy (Appendix S2, supporting information), several health-
care providers have developed severe COVID-19 and died.
InHongKong (Appendix S3, supporting information) none
of the healthcare workers have been infected byCOVID-19
in the hospital setting. It is too early to predict the total
impact on the healthcare workforce. A grave global con-
cern is the universal lack of PPE, which is likely to have a
huge impact on the morbidity and mortality of healthcare
personnel from contracting COVID-19 owing to a lack of
appropriate protection.
Reconsidering or redirection of choice
of management
In a scenario in which the goal is to reduce unwanted
admissions to hospital, to avoid surgery (if at all possible),
or delay or defer interventions until resources or risk can
be better controlled, there is a need to reconsider treat-
ment options or management strategies for several disease
groups. Surgeons are used to decision-making processes,
albeit usually based on a broad array of clinical, personal
and institutional variables40. A pandemic scenario changes
the reasoning and premise by which decisions will be made.
In general, a risk-averse strategy should be implemented.
Notably, this may result in changes in management and
outcomes for surgical conditions.
A template prescription of which patients should be pre-
ferred for a specific management option is not possible.
Each patient should be evaluated individually. However, in
a situation where resources are scarce, one should not treat
or prioritize on a first-come, first-served principle41. Each
healthcare system may have different principles by which
decisions are guided. Ideally, decisions should not be based
on local hospital directions. Where healthcare is delivered
jurisdictionally, there should be governing principles orga-
nized regionally. Individually, healthcare workers should
consult colleagues in teams to reach decisions in settings
of priorities, end-of-life-decisions or when there is a need
to rationalize resources41, in order to avoid fatigue, burn
out, guilt and unbearable psychological pressures.
Surgical services during pandemic phase
Surgical care that is not essential or time-critical can be
delayed and deferred to a later date when the pandemic
subsides16. However, even in the midst of a pandemic cer-
tain procedure types must be performed, including appro-
priate cancer treatment, emergency surgery and urgent
transplantation, as these are considered life-saving proce-
dures with curative potential. A complete neglect of certain
surgical services would be considered unwanted collateral
damage, and inadvertently increase the number of deaths
and life-years lost owing to the COVID-19 pandemic. This
can create ethical dilemmas at a time of scarce resources
and high pressure on critical care staff 23,41,42, especially
when surgical theatres are shut down or reduced to a min-
imum of activity, and triage for the indicated and urgent
operations is required. Several surgical societies and orga-
nizations (Table 1; Table S3, supporting information) have
launched lists of proposed procedures and ways of priori-
tizing these during times of high disease pressure.
Patients with conditions in need of high-priority
elective or urgent surgery
There is no consensus on what types of non-elective,
non-emergency procedures should proceed, and under
what circumstances. The definition of elective surgery
varies widely, but general recommendations have been
issued by several surgical societies and organizations
(Table 1) to advise on priorities and support cancellations
or deferred procedures. A definition of major surgery is
also lacking, and varies between surgeons, regions and
even subdisciplines. A recent Delphi study43 agreed that
‘significant co-morbidities’ were the only preoperative
factor retained to define major surgery. Notably, several
of the risk factors in patients that predict risk of com-
plications and need for intensive care after surgery are
also the factors associated with higher risk of poor out-
comes in COVID-19, including increasing age, diabetes,
hypertension and cardiac disease44,45.
A conceptual framework might stratify medically nec-
essary, time-sensitive surgery46 by variables that include
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the nature of the disease, the nature of the procedure
and the nature of the patient. As regards procedures,
variables to consider include the duration of operation,
potential for ICU care, length of hospital stay, surgical
site and risk of aerosolized droplets. Disease-specific con-
siderations include the risk of delay on outcome (2, 4 or
8weeks or longer) and alternative non-surgical options
for therapy. Patient-specific considerations, in addition to
COVID-19 or influenza-like illness status, might include
age, pre-existing cardiopulmonary disease, immunocom-
petence and diabetes.
With some early reports of a high risk of postoperative
morbidity and death in patients exposed to COVID-19 at
the time of surgery14,36, a set of minimum screening initia-
tives should take place until better data are available. For
patients with urgent and non-emergency surgical condi-
tions requiring operation, before admission (or on admis-
sion in a pathway evaluation if admitted semiurgently)
there should be an interview with attention to sick contacts
and extent of social isolation performed. A single swab with
PCR or chest CT on the day before surgery to screen for
COVID-19 is recommended by some47,48. The applica-
bility of these measures may change as knowledge, testing
capability and sensitivity evolve, and with prevalence of
COVID-19 (and evolving immunity) among the public.
Considering risk of surgery during COVID-19
pandemic
Patients with COVID-19 present with the classical symp-
toms of fever, dry cough and difficulty breathing44,49–51,
but it is increasingly being recognized that a large number
of patients have minimal or no symptoms in the early
course of the disease. Digestive symptoms may have
been overlooked in early reports, as increasing num-
bers of patients are being reported to have abdominal
symptoms52–55. An increasing number of reports are
suggesting that other symptoms may be associated with
COVID-19, such as anosmia56,57. A thorough history of
risk and exposure as well as testing should be done for all
patients admitted for elective surgery.
The SARS-CoV-2 virus is particularly contagious
through transmission via droplets. Airborne transmission
via aerosols remains uncertain, debated and of concern.
Hence, the premise for delivering essential diagnostic
and therapeutic interventions for surgical conditions has
already changed. Evaluation of mitigation strategies and
risk is needed in order to unlock current changes to prac-
tice. The implications of transmission risk uncertainty may
last months, if not years, for the practice of surgery.
Outcomes after surgery in COVID-19 have not yet
been investigated systematically, but anecdotal experience
reports unfavourable outcomes even after some routine
surgical operations (such as cholecystectomy, hernia repair
and hysterectomy)14,36. The effects of COVID-19 on
surgery (and vice versa) are not known. Pathological
changes in blood coagulation58, inflammatory response59,
and co-morbidities added to single or multiple organ
failures60 may be considered as mechanisms for added risk
for surgery.
As a general recommendation, surgery on patients
who are SARS-CoV-2-positive or have symptomatic
COVID-19 should be undertaken only in true emergency
circumstances. For patients in the ICU who develop a
surgical condition, surgery should be considered when
discussed as a likely life-saving intervention with benefit
to the patient. Non-surgical or minimally invasive alterna-
tives should be entertained, if possible, such as draining a
severely infected gallbladder rather than operating.
Surgery for patients with COVID-19 should be per-
formed in designated theatres, preferably located in the
periphery of other theatres, and with negative-pressure
room ventilation11,13,17,18. Procedure for transport
of patients with COVID-19 should be followed
strictly – either from ward or from ICU to theatres61.
If the patient is not already intubated, precautions for
intubation should be adhered to, as this is considered to
be a procedure with high aerosol risk12,17,62. Perioperative
guidelines (Table 1) must be consulted, as these are evolving
based on new knowledge11–13.
Emergency general surgery admissions
Patients who are admitted for an acute abdomen (and in
need of surgery) may be co-infected with COVID-19, and
hence represent a risk for contamination of healthcare
personnel and other patients, even when not feeling ill or
experiencing severe symptoms suggestive of COVID-19.
With an increasing number of infected yet asymptomatic
subjects in the population, a high clinical suspicion for
non-typical symptoms is also warranted. Notably, several
hospitals have started to include CT of the thorax as a rou-
tine part of diagnostic evaluation (and COVID-19 screen-
ing) if cross-sectional imaging of the abdomen is part of
the planned work-up, as there have been several anecdo-
tal reports of diagnosis of typical lung findings in patients
without respiratory symptoms or other signs suggestive
of COVID-19. Typically, ground-glass findings may be
present in the early phase of the disease course63. Only after
finding the CT signs, and testing the patients using regular
swabs, was the disease actually confirmed as SARS-CoV-2.
This poses a particular challenge to the healthcare system
to avoid potentially admitting and treating patients with
otherwise no suspect symptoms.
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Trauma admissions still occur during a pandemic,
although there are unconfirmed reports of a reduction
in acute and trauma admissions as an effect of the social
distancing and overall reduced activity in society. Although
trauma admissions may drop, so may recruitment of the
regular pool of blood donors, potentially leading to a
shortage of blood products in some systems. In addi-
tion, coagulation may be affected in patients who are
COVID-19-positive, potentially adding to issues with
bleeding injuries58. As reported in Seattle, Washington,
in the early phase of the outbreak64, the overall use of
blood products decreased significantly among inpatients
and remained stable in the outpatient clinic at the starting
point. However, owing to the confinement situation taking
place in some countries, blood reserves could be affected as
donations decrease. Although coronavirus predominantly
infects the respiratory tract, the potential risk of transmis-
sion by transfusion needs to be addressed. One of the main
concerns is the ability asymptomatic patients may have to
infect during the incubation period65. Appropriate testing
of donors who give blood during the pandemic should be
put in place.
Transplant activity
Organ transplantation is a life-saving procedure. Limit-
ing access to transplantation is associated with a signifi-
cant loss of prognosis for most patients on the transplant
list. How the pandemic affects organ transplantation is
related to impact on the donor pool, risk of transmission
of infection, risk to living donors and overall access to
scarce resources66,67. Donors must be tested and confirmed
as COVID-19-negative. The risk of bloodborne transmis-
sion during transplantation appears to be low, as only about
1–15 per cent of subjects appear to have circulating virus
RNA50. Lung transplantation poses a particular problem.
In planning the reorganization of transplant programmes
during the pandemic, a phased approach scaled to the cur-
rent severity of the pandemic has been suggested. Accord-
ingly, most centres have initially stopped elective living
donor programmes while maintaining other transplant
services66–68. The scenario of submitting a healthy donor
to a major surgical procedure concomitant with the risk
of being infected with COVID-19 must be considered and
calls for caution, even if cases of successful recovery exist69.
Furthermore, the competition for scarce resources related
to hospital and ICU beds and blood transfusions mandates
strict prioritization. As the overall strain of the pandemic
intensifies, this might dynamically change organ allocation
and prioritization policies66–68.
In times of crisis and shortage of resources, several ethi-
cal challenges may present23,24,42. The competing risks and
need to allocate resources may require a change in patient
priorities in several surgical disciplines, notably transplan-
tation, cancer surgery and other high-risk procedures. As a
result, some patients may unfortunately not be offered the
treatment they would otherwise have received.
Preparing surgical services for postpandemic
phase
The cancellation of all elective operations creates a huge
backlog of patients who have been, or would be, seen for
planned surgery (Fig. 2). With a long-lasting lockdown
and social distancing in effect, there will be millions of
operations cancelled, deferred or simply not done at all
over the coming months. Surgery is already recognized
as a scarce resource in much of the world70–72, with a
global challenge to provide safe surgery and anaesthesia as
a recognized area of priority73.
Although the majority of infected people experience a
mild disease, there are currently only anecdotal reports
on potential adverse outcomes even after relatively minor,
elective surgical procedures14,36. Until better data are at
hand, the uncertainty will affect management during the
surge of the pandemic and also have implications in the
long term during the ‘tail’ of the pandemic (Fig. 1), as
COVID-19 may be present in the general population
for months ahead (until vaccine is universally available),
until proper systems for high-accuracy testing and avail-
ability allow proper protection of patients and healthcare
providers alike.
There is a lack of data on the actual risk of several
procedures that are potentially aerosol-generating,
including thoracoscopic interventions, laparoscopic
abdominal surgery, endoscopic procedures, and open
surgery performed with traditional equipment (including
electrocautery and tissue-sealing devices)14,26,74. Safety
hazards need to be addressed and investigated by proper
methods to arrive at guidelines that protect surgical teams
appropriately15,16. Changing clinical practice to a point
that jeopardizes surgical care or even leads to substandard
management in fear of COVID-19 should be avoided.
Rebuilding surgical capacity after pandemic
There is no existing knowledge as to what impact this loss
of surgical capacity will have on patients’ surgical condi-
tion and associated health, or in terms of well-being, func-
tional capacity, risk of loss of function or adverse effects
on prognosis. It is known from cancellations under normal
circumstances that patients can experience feelings of sad-
ness, disappointment, anger, frustration and stress75. This
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Fig. 2 Proposed framework for surgical planning through pandemic phases
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 For admitted emergencies
Tailor to levels of influence*
 Emergency general surgery
 Trauma services
 Essential elective surgery
 Cancer surgery
 Transplant surgery
Cancel non-essential elective surgery
Create pandemic pathways/zones
 Hub–spoke models; designated hospitals
 or zone(s) within hospital
 Diagnostic pathways: clean/contaminated
 operating rooms/theatres
 Wards (repurpose; restaff)
Reorganize surgical services
 Build capacity for ICU/respiratory support
 Clear surgical wards
 Cancel/reorganize outpatient visits
Test awareness and capacity
 Symptoms
 Tests
 Alternatives (e.g. imaging)
Training and simulation of staff (i.e. PPE; pathways; new roles)
Information to personnel – open, continued, concise, changing/adapting
Evaluation and analyses
Preparation phase Pandemic phase Postpandemic phase and recovery
Preparedness
The framework is a basic overview of steps for surgical services to incorporate, and is not exhaustive. Currently, no universal framework for planning of
surgical services and maintenance of capacity exists in the governing organizations. Surgery may be affected disproportionally by the loss of space and
personnel, and the uncertainty of associated risks to patients and with exposure to procedures, compared with other disciplines. Training and simulation for
personnel (donning and doffing; getting used to specific personal protective equipment (PPE); logistics and transport) is important in every phase. Clear
and continued communication of information and knowledge is of the essence in all phases. *Depending on burden to hospital/region.
comes in addition to the potential economic consequence
(loss of work, sick leave or inability to maintain occupancy)
and impact on family life.
There are currently no robust data available to model
the number of operations being put on hold and how this
backlog will be addressed in the aftermath of the pandemic.
However, rough estimates suggest that approximately 330
million operations are done worldwide annually76, the vast
majority in high-income regions now exercising a strong
policy of cancellation of all non-essential surgery (North
America and European countries). With a global average
of about six million procedures per week, the aggregated
numbers of patients who will be affected over the coming
months are growing at a concerning pace. Little is known
about the timeline or duration of these cancellations, or
what criteria should be used to reopen these services.
In the current pandemic, patients may prefer to have
non-essential elective surgery deferred owing to fear of
contracting the disease while in hospital. However, this fear
may also lead patients not to seek timely care for conditions
that would otherwise have been correctable or curable by
presenting at an earlier stage; loss of function and reduced
life expectancy may be the result of delayed presentation
and an untimely diagnosis. This burden will only increase
with the duration and severity of the pandemic.
Future research and need for better knowledge
The current situation is unparalleled in modern history,
and so no readily available information exists to compare
or project the effect of disruption of surgical services on
public health during the pandemic. Medical resources and
© 2020 The Authors. British Journal of Surgery published by John Wiley & Sons Ltd www.bjs.co.uk BJS
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response systems must be evaluated after this pandemic in
order to prepare for the next2.
Data on the effects of surgical cancellation on patient
well-being, including emotional and physical health, are
much needed. In addition, the effect of the backlog of oper-
ations and the aftermath of the pandemic will need to be
analysed. As elective surgery has been cancelled on a scale
never before seen in modern history, the collateral damage
to health and well-being, maintenance of function, and risk
of shortened lifespan is present for patients in countries of
all income designations. However, the implicit assumption
is that the poor and marginalized will be affected most
severely. For this reason, an equity-based approach to crit-
ical analysis will provide answers that could guide future
health system strengthening that works toward a socially
just construction of surgical systems.
Finally, we call for a structured framework for evalua-
tion of this COVID-19 pandemic vis à vis surgical care
delivery. It is imperative to understand how and why dif-
ferent countries were prepared (or not), how the effects of
the pandemic on surgical services were mitigated, and how
some countries managed the delivery of surgical care in
their healthcare services better than others. A strong advo-
cacy agenda is needed that includes investigation, planning,
research and communication for surgical and anaesthe-
sia services for future pandemics. Surgical delivery before,
during and after a pandemic, owing to its cross-cutting
nature and synergistic effects on health systems at large,
needs to be built into theWHO agenda for national health
planning.Wemust ask the questions that will lead to appro-
priate change in how countries should construct surgical
systems in terms of infrastructure, workforce, care deliv-
ery, informationmanagement, financing and governance to
prepare for future events on this scale.
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